title: The 2-5A/RNase L/RNase L inhibitor (RLI) [correction of (RNI)] pathway regulates mitochondrial mRNAs stability in interferon alpha-treated H9 cells.
abstract: Interferon alpha (IFNalpha) belongs to a cytokine family that exhibits antiviral properties, immuno-modulating effects, and antiproliferative activity on normal and neoplasic cells in vitro and in vivo. IFNalpha exerts antitumor action by inducing direct cytotoxicity against tumor cells. This toxicity is at least partly due to induction of apoptosis. Although the molecular basis of the inhibition of cell growth by IFNalpha is only partially understood, there is a direct correlation between the sensitivity of cells to the antiproliferative action of IFNalpha and the down-regulation of their mitochondrial mRNAs. Here, we studied the role of the 2-5A/RNase L system and its inhibitor RLI in this regulation of the mitochondrial mRNAs by IFNalpha. We found that a fraction of cellular RNase L and RLI is localized in the mitochondria. Thus, we down-regulated RNase L activity in human H9 cells by stably transfecting (i) RNase L antisense cDNA or (ii) RLI sense cDNA constructions. In contrast to control cells, no post-transcriptional down-regulation of mitochondrial mRNAs and no cell growth inhibition were observed after IFNalpha treatment in these transfectants. These results demonstrate that IFNalpha exerts its antiproliferative effect on H9 cells at least in part via the degradation of mitochondrial mRNAs by RNase L.
authors.affiliation: EP2030 CNRS, Institut de Génétique Moléculaire, 1919 route de Mende, 34293 Montpellier, France.
authors.forename: F
authors.initials: F
authors.lastname: Le Roy
authors.forename: C
authors.initials: C
authors.lastname: Bisbal
authors.forename: M
authors.initials: M
authors.lastname: Silhol
authors.forename: C
authors.initials: C
authors.lastname: Martinand
authors.forename: B
authors.initials: B
authors.lastname: Lebleu
authors.forename: T
authors.initials: T
authors.lastname: Salehzada
mesh_terms: D018528:ATP-Binding Cassette Transporters; D000227:Adenine Nucleotides / Q000378:metabolism*; D001483:Base Sequence; D002455:Cell Division / Q000187:drug effects; D018833:Chaperonins; D017931:DNA Primers; D004722:Endoribonucleases / Q000037:antagonists & inhibitors / Q000378:metabolism*; D006801:Humans; D016898:Interferon-alpha / Q000494:pharmacology*; D008928:Mitochondria / Q000235:genetics*; D009843:Oligoribonucleotides / Q000378:metabolism*; D011506:Proteins / Q000378:metabolism*; D012333:RNA, Messenger / Q000235:genetics* / Q000378:metabolism; D014407:Tumor Cells, Cultured
chemical_list: C501917:ABCE1 protein, human; D018528:ATP-Binding Cassette Transporters; D000227:Adenine Nucleotides; D017931:DNA Primers; D016898:Interferon-alpha; D009843:Oligoribonucleotides; D011506:Proteins; D012333:RNA, Messenger; C023505:2',5'-oligoadenylate; D004722:Endoribonucleases; C031956:2-5A-dependent ribonuclease; D018833:Chaperonins